Wednesday, March 04, 2026

Financial News Conference on Fiscal 2025

Bayer delivers upgraded 2025 ambition, projects solid 2026, focused on strategic priorities
  • Group sales at 45.575 billion euros (Fx & p adj. plus 1.1 percent), negative currency effects of 1.742 billion euros
  • EBITDA before special items at 9.669 billion euros (minus 4.5 percent)
  • Core earnings per share at 4.91 euros (minus 2.8 percent)
  • Net income at minus 3.620 billion euros – high special charges for litigations  
  • Free cash flow declines to 2.084 billion euros, net financial debt reduced to 29.843 billion euros
  • Proposed dividend of 0.11 euros per share
  • Earnings figures and outlook reflect class settlement agreement to resolve current and future Roundup™ (glyphosate) claims
  • Outlook for 2026: Stable sales and earnings (Fx adj.), free cash flow to be heavily impacted by settlement payments
  • Advancing innovation opportunities across divisions to drive mid-term growth

NEWS RELEASE

Strategy and Financial Update

Bayer CEO Bill Anderson provides an update on the fiscal 2025 and gives an outlook for 2026 - in 90 seconds!